【Polaris Pharmaceuticals-KY】Adjustment of Organizational Structure and Manpower for US Subsidiaries
Polaris Pharmaceuticals announced on May 25, 2026, that it is adjusting the organizational structure and manpower of its US subsidiaries (DRx and PPI) to improve operational efficiency and reduce fixed costs.
📋 Article Processing Timeline
- 📰 Published: May 25, 2026 at 09:00
- 🔍 Collected: May 26, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 1, 2026 at 23:39 (159h 38m after Collected)
1. Date of event: 2026/05/25. 2. Company name: Polaris Pharmaceuticals Group. 3. Reason: The board has reviewed the organizational structure and resource allocation of its Northern California subsidiary (DRx) and Southern California subsidiary (PPI). Based on global industry changes and capital efficiency, the board approved an optimization plan. The goal is to enhance operational efficiency and reduce fixed costs without affecting core functions or product development. 4. Measures: The company will continue to promote resource allocation planning to strengthen financial health.
FAQ
Why is the company restructuring its US subsidiaries?
To improve operational efficiency and reduce fixed costs.